Clinical Case Review: Medical Team’s Follow-Up Recommendation for Ongoing Cell Therapy and Developmental Support in Autism Spectrum Disorder (ASD)

This review concerns a school-aged pediatric client with Autism Spectrum Disorder (ASD) who has previously undergone a course of supportive cell therapy and continues to receive developmental and occupational therapy.

Recommended Evaluation of Developmental Progress and Current Status Current occupational therapy assessment demonstrates good participation and responsiveness to visual and gesture cues. Strengths are noted in visual perception, colour recognition, pattern matching, fine motor control, and the ability to perform structured tasks.

However, sustained attention remains limited, and further development is required in communication, social turn-taking, handwriting precision, motor planning, and higher-level cognitive skills.

The patient’s ATEC score has shown an overall positive trend, moving from a previously recorded score of approximately 58 to approximately 43 at the most recent evaluation. This suggests improvement in developmental and behavioural functioning over time; however, the medical team notes that this improvement should not be attributed to any single intervention, since natural maturation and ongoing continuous therapies may also be contributing factors.

Recommended Role of Cell Therapy at This Stage The patient recently completed a course of cell therapy, involving both systemic and targeted hospital-based administration. Given this, the medical team recommends no immediate repeat cellular treatment at this stage. The priority now is objective follow-up to determine the clinical response to the recent supportive protocol before any further biological intervention is considered.

Proposed Supportive Treatment Plan The medical team recommends that the patient continue Occupational Therapy and Speech/Language Therapy, with particular emphasis on:

• Sustained attention
• Receptive and expressive communication
• Social interaction and turn-taking
• Executive function
• Fine motor skills
• Motor planning

Recommended Rehabilitation and Follow-Up The medical team recommends a repeat developmental assessment and ATEC evaluation at approximately 3 and 6 months following the supportive protocol, using the most recent ATEC score as the baseline.

Repeat laboratory evaluation should also include:

• Complete blood count (CBC)
• Iron profile
• Thyroid function
• Renal and liver function
• Vitamin D, B12, and folate

A multidisciplinary pediatric review is recommended by the medical team if thyroid or iron abnormalities remain present.

Overall Recommendation From the medical team’s perspective, this approach is more clinically sound than proceeding directly to another cell therapy course. This case now has a strong, well-documented baseline following the most recent supportive cycle, and the most valuable next step is to observe how the ATEC score of approximately 43 evolves over the coming 3–6 months before making any decisions regarding further biological support.

Further cell therapy should therefore be considered by the medical team only after reviewing the patient’s objective developmental progress and medical status at follow-up, rather than being scheduled preemptively.